The Diversity of the Intestinal Flora Disturbed After Feeding Intolerance Recovery in Preterm Twins

Ying Li1,2,3, Chunhong Jia2,3, Xiaojun Lin2

  • 1Department of Neonatology, The First Affiliated Hospital of Jinan University, Guangzhou, China.

Insights

Feeding intolerance in premature infants alters gut bacteria diversity and composition even after recovery. This condition may disrupt the natural development of the infant intestinal bacterial community.

Area of Science:

  • Neonatal microbiome research
  • Gastrointestinal health in premature infants

Background:

  • Feeding intolerance (FI) is a common complication in premature infants, linked to poor growth and necrotizing enterocolitis.
  • The gut microbiome's role in FI is established, but its long-term impact post-recovery remains unclear.

Purpose of the Study:

  • To investigate the gut microbiome's diversity and composition in premature infants following feeding intolerance recovery.
  • To compare the intestinal flora between infants with a history of feeding intolerance and those with normal feeding tolerance.

Main Methods:

  • 16S rRNA gene sequencing of fecal samples from 11 pairs of premature twins/triplets.
  • Longitudinal sample collection from admission up to 7 weeks or discharge.
  • Analysis of microbial beta-diversity, predominant phyla, specific bacterial taxa, and KEGG pathways.

Main Results:

  • No significant difference in overall beta-diversity between FI and feeding tolerance (FT) groups post-recovery.
  • Significant differences in predominant phyla: Proteobacteria in FI group, Firmicutes in FT group.
  • Distinct bacterial taxa and KEGG pathways (e.g., metabolism, DNA repair) differed significantly between groups post-recovery.

Conclusions:

  • Significant differences in intestinal flora diversity persist after feeding intolerance recovery in premature infants.
  • Feeding intolerance appears to disrupt the normal successional patterns of the infant gut bacterial community.

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
85.0K
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
884
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
485
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
411